Related News

March 29, 2020

Below are the three companies in the Pharmaceuticals industry with the highest debt to equity ratios. The Debt/Equity ratio measures a company's leverage and a high level often implies that a company has financed much of its growth with debt....

March 28, 2020

Below are the three companies in the Pharmaceuticals industry with the highest debt to equity ratios. The Debt/Equity ratio measures a company's leverage and a high level often implies that a company has financed much of its growth with debt....

March 18, 2020

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 4 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

...

March 15, 2020

Below are the three companies in the Pharmaceuticals industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Neos...

March 14, 2020

Below are the three companies in the Pharmaceuticals industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Neos...

March 12, 2020

Below are the three companies in the Pharmaceuticals industry with the highest debt to asset ratios. The Debt/Asset ratio shows the proportion of a company's assets that are financed through debt. If the ratio is greater than one, most of the...

March 10, 2020

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 4 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

...

February 29, 2020

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 3 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

Over...

February 29, 2020

Below are the three companies in the Pharmaceuticals industry with the highest debt to equity ratios. The Debt/Equity ratio measures a company's leverage and a high level often implies that a company has financed much of its growth with debt....

February 21, 2020

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 3 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

In the...